Currently out of the existing stock ratings of Olivia Brayer, 69 are a BUY (61.06%), 44 are a HOLD (38.94%).

Olivia Brayer

Work Performance Price Targets & Ratings Chart

Analyst Olivia Brayer, currently employed at BAIRD, carries an average stock price target met ratio of 67.24% that have a potential upside of 35.23% achieved within 138 days. Previously, Olivia Brayer worked at CANTOR FITZGERALD, BAML.

Olivia Brayer’s has documented 222 price targets and ratings displayed on 14 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CTMX, CytomX Therapeutics at 04-Feb-2026.

Wall Street Analyst Olivia Brayer

Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for BMY (BRISTOL-MYERS SQUIBB COMPANY) at 7/22/2024. The price target of $45 was fulfilled within 4 days with a profit of $5.27 (13.26%) receiving and performance score of 33.16.

Average potential price target upside

of $100.32 (28.87%) on UTHR (UNITED THERAPEUTICS).
of $90.22 (30.3%) on AMGN (AMGEN).
of $65.62 (6.1%) on REGN (REGENERON PHARMACEUTICALS).

ALNY Alnylam Pharmaceuticals AMGN Amgen AUPH Aurinia Pharmaceuticals BMRN Biomarin Pharmaceutical BMY Bristol-Myers Squibb Company CTMX CytomX Therapeutics GILD Gilead Sciences GRPH Graphite Bio MNKD MannKind Corp REGN Regeneron Pharmaceuticals UTHR United Therapeutics VNDA Vanda Pharmaceuticals VRNA Verona Pharma PLC ADR VRTX Vertex Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Derek Archila (WELLS FARGO)